Lyndsey Elizabeth Crennen, the CAO of $MLAB, sold 442 shares of the company on 06-22-2026 for an estimated $39,559. We received data on the trade from a recent SEC filing. This was a sale of approximately 18.0% of their shares of this class of stock. Following this trade, they now own 2,020 shares of this class of $MLAB stock.
$MLAB Insider Trading Activity
$MLAB insiders have traded $MLAB stock on the open market 9 times in the past 6 months. Of those trades, 3 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $MLAB stock by insiders over the last 6 months:
- JOHN SAKYS (CFO) has made 0 purchases and 2 sales selling 4,050 shares for an estimated $376,871.
- BRIAN DAVID ARCHBOLD (SVP Operations) has made 0 purchases and 2 sales selling 3,667 shares for an estimated $341,745.
- SHIRAZ SHABANALI LADIWALA purchased 3,500 shares for an estimated $252,805
- R TONY TRIPENY purchased 1,315 shares for an estimated $99,940
- MARK CHRISTOPHER CAPONE purchased 1,301 shares for an estimated $99,331
- LYNDSEY ELIZABETH CRENNEN (CAO) has made 0 purchases and 2 sales selling 560 shares for an estimated $51,509.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$MLAB Hedge Fund Activity
We have seen 86 institutional investors add shares of $MLAB stock to their portfolio, and 71 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CONESTOGA CAPITAL ADVISORS, LLC removed 426,457 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $33,476,874
- SIMCOE CAPITAL MANAGEMENT, LLC removed 190,929 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $14,987,926
- GENEVA CAPITAL MANAGEMENT LLC removed 178,713 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $15,801,803
- LONG PATH PARTNERS LP added 178,360 shares (+78.5%) to their portfolio in Q1 2026, for an estimated $15,770,591
- GLENMEDE TRUST CO NA removed 146,544 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $11,503,704
- AQR CAPITAL MANAGEMENT LLC added 100,424 shares (+143.2%) to their portfolio in Q1 2026, for an estimated $8,879,490
- MASON CAPITAL MANAGEMENT LLC removed 70,300 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $6,215,926
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$MLAB Revenue
$MLAB had revenues of $65.1M in Q3 2026. This is an increase of 3.64% from the same period in the prior year.
You can track MLAB financials on Quiver Quantitative's MLAB stock page.
You can access data on MLAB stock through the Quiver Quantitative API.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
